Tampon Samplings With Longer Cervicovaginal Cell Exposures Are Equivalent to Two Consecutive Swabs for the Detection of High-Risk Human Papillomavirus
- 1 November 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 29 (11) , 628-636
- https://doi.org/10.1097/00007435-200211000-00003
Abstract
Self-sampling for human papillomavirus (HPV) is useful for triage of ASCUS Papanicolaou (Pap) smears. Tampons with 10-second cervicovaginal cell exposure can detect HPV but appear to be less efficient than two consecutive swabs. The purpose of this study was to evaluate increased vaginal tampon exposures for detecting high-risk HPV. This longitudinal cohort study followed women who self-sampled weekly with tampons for progressively longer periods of time. A tampon was inserted for 10 seconds at the office visit and 1 hour, 4 hours, and overnight for the three subsequent home samples. Two concurrent swabs were used with each tampon sampling for contemporaneous comparisons. The MY09/MY11 PCR primer system with reverse line blot detection strips was used to detect 18 distinct high-risk HPV types. Of the 309 tampons and 618 swabs used at home, 83% were returned. Among normal women, the 10-second tampon detected fewer with normal histology and high-risk HPV than did its swabs (P = 0.0412), but the 1-hour, 4-hour, and overnight tampons had high-risk-HPV detection rates equal to their swabs. In women with CIN, all tampons and swabs equally identified those with high-risk HPV. Self-sampling for HPV detection is acceptable, feasible, and technically accurate for both tampons with longer cervicovaginal exposures and swabs. The choice of technique is dependent on the woman, her culture, and her clinician.Keywords
This publication has 17 references indexed in Scilit:
- 2001 Consensus Guidelines for the Management of Women With Cervical Cytological AbnormalitiesJAMA, 2002
- Randomized clinical trial of PCR–determined human papillomavirus detection methods: Self-sampling versus clinician-directed–Biologic concordance and women's preferencesAmerican Journal of Obstetrics and Gynecology, 2002
- Negative Predictive Value of Human Papillomavirus Test Following Conization of the Cervix UteriGynecologic Oncology, 2001
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical CancerJAMA, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detectionHuman Pathology, 1999
- Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United StatesSexually Transmitted Diseases, 1999
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Comparison between Methods for Human Papillomavirus DNA Testing: A Model for Self-Testing in Young WomenThe Journal of Infectious Diseases, 1993